Downstream Processing in the Biotechnology Industry

The biotechnology industry today employs recombinant bacteria, mammalian cells, and transgenic animals for the production of high-value therapeutic proteins. This article reviews the techniques employed in this industry for the recovery of these products. The methods reviewed extend from the centrif...

Full description

Saved in:
Bibliographic Details
Published inMolecular biotechnology Vol. 22; no. 1; pp. 87 - 98
Main Author Kalyanpur, Manohar
Format Journal Article
LanguageEnglish
Published Totowa, NJ Humana Press 01.09.2002
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN1073-6085
1073-6085
1559-0305
DOI10.1385/MB:22:1:087

Cover

More Information
Summary:The biotechnology industry today employs recombinant bacteria, mammalian cells, and transgenic animals for the production of high-value therapeutic proteins. This article reviews the techniques employed in this industry for the recovery of these products. The methods reviewed extend from the centrifugation and membrane filtration for the initial clarification of crude culture media to the final purification of the products by a variety of membrane-based and chromatographic methods. The subject of process validation including validation of the removal of bacterial and viral contaminants from the final products is also discussed with special reference to the latest regulatory guidelines.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ISSN:1073-6085
1073-6085
1559-0305
DOI:10.1385/MB:22:1:087